GNE-375
Based on 1 Customer Validation
GNE-375 is a potent and highly selective BRD9 inhibitor with an IC50 of 5 nM. GNE-375 shows >100-fold selective for BRD9 over BRD4, TAF1, and CECR2. GNE-375 decreases BRD9 binding to chromatin.
For research use only. We do not sell to patients.
- Purity: 99.93%
- CAS No.: 1926989-06-1
- Formula: C25H29N3O5
- Molecular Weight:451.51
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
BRD9 5 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 769-P | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human 769-P cells measured after 3 days
Cytotoxicity against human 769-P cells measured after 3 days
|
[PMID: 28606761] |
| 786-0 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human 786-0 cells measured after 3 days
Cytotoxicity against human 786-0 cells measured after 3 days
|
[PMID: 28606761] |
| A2780 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human A2780 cells measured after 3 days
Cytotoxicity against human A2780 cells measured after 3 days
|
[PMID: 28606761] |
| A-375 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human A-375 cells measured after 8 days
Cytotoxicity against human A-375 cells measured after 8 days
|
[PMID: 28606761] |
| A549 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human A549 cells measured after 8 days
Cytotoxicity against human A549 cells measured after 8 days
|
[PMID: 28606761] |
| ABC-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ABC-1 cells measured after 8 days
Cytotoxicity against human ABC-1 cells measured after 8 days
|
[PMID: 28606761] |
| ACHN | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ACHN cells measured after 3 days
Cytotoxicity against human ACHN cells measured after 3 days
|
[PMID: 28606761] |
| AMO1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human AMO1 cells measured after 8 days
Cytotoxicity against human AMO1 cells measured after 8 days
|
[PMID: 28606761] |
| AMO1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human AMO1 cells measured after 3 days
Cytotoxicity against human AMO1 cells measured after 3 days
|
[PMID: 28606761] |
| AU565 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human AU565 cells measured after 8 days
Cytotoxicity against human AU565 cells measured after 8 days
|
[PMID: 28606761] |
| AU565 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human AU565 cells measured after 3 days
Cytotoxicity against human AU565 cells measured after 3 days
|
[PMID: 28606761] |
| BEN | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human BEN cells measured after 8 days
Cytotoxicity against human BEN cells measured after 8 days
|
[PMID: 28606761] |
| BJAB | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human BJAB cells measured after 8 days
Cytotoxicity against human BJAB cells measured after 8 days
|
[PMID: 28606761] |
| BJAB | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human BJAB cells measured after 3 days
Cytotoxicity against human BJAB cells measured after 3 days
|
[PMID: 28606761] |
| BT-20 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human BT-20 cells measured after 3 days
Cytotoxicity against human BT-20 cells measured after 3 days
|
[PMID: 28606761] |
| BT-474 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human BT-474 cells measured after 3 days
Cytotoxicity against human BT-474 cells measured after 3 days
|
[PMID: 28606761] |
| BT-549 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human BT-549 cells measured after 8 days
Cytotoxicity against human BT-549 cells measured after 8 days
|
[PMID: 28606761] |
| CA46 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CA46 cells measured after 8 days
Cytotoxicity against human CA46 cells measured after 8 days
|
[PMID: 28606761] |
| CA46 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CA46 cells measured after 3 days
Cytotoxicity against human CA46 cells measured after 3 days
|
[PMID: 28606761] |
| Caco-2 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Caco-2 cells measured after 8 days
Cytotoxicity against human Caco-2 cells measured after 8 days
|
[PMID: 28606761] |
| CAL-120 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAL-120 cells measured after 8 days
Cytotoxicity against human CAL-120 cells measured after 8 days
|
[PMID: 28606761] |
| CAL-12T | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAL-12T cells measured after 8 days
Cytotoxicity against human CAL-12T cells measured after 8 days
|
[PMID: 28606761] |
| CAL-12T | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAL-12T cells measured after 3 days
Cytotoxicity against human CAL-12T cells measured after 3 days
|
[PMID: 28606761] |
| CAL-148 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAL-148 cells measured after 3 days
Cytotoxicity against human CAL-148 cells measured after 3 days
|
[PMID: 28606761] |
| CAL-51 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAL-51 cells measured after 8 days
Cytotoxicity against human CAL-51 cells measured after 8 days
|
[PMID: 28606761] |
| CAL-85-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAL-85-1 cells measured after 3 days
Cytotoxicity against human CAL-85-1 cells measured after 3 days
|
[PMID: 28606761] |
| Calu-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Calu-1 cells after 8 days
Cytotoxicity against human Calu-1 cells after 8 days
|
[PMID: 28606761] |
| Calu-3 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Calu-3 cells measured after 8 days
Cytotoxicity against human Calu-3 cells measured after 8 days
|
[PMID: 28606761] |
| Calu-6 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Calu-6 cells after 8 days
Cytotoxicity against human Calu-6 cells after 8 days
|
[PMID: 28606761] |
| CAMA-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAMA-1 cells measured after 8 days
Cytotoxicity against human CAMA-1 cells measured after 8 days
|
[PMID: 28606761] |
| CAMA-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CAMA-1 cells measured after 3 days
Cytotoxicity against human CAMA-1 cells measured after 3 days
|
[PMID: 28606761] |
| ChaGo-K-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ChaGo-K-1 cells measured after 8 days
Cytotoxicity against human ChaGo-K-1 cells measured after 8 days
|
[PMID: 28606761] |
| CoCM-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CoCM-1 cells measured after 3 days
Cytotoxicity against human CoCM-1 cells measured after 3 days
|
[PMID: 28606761] |
| COLO 205 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human COLO 205 cells measured after 8 days
Cytotoxicity against human COLO 205 cells measured after 8 days
|
[PMID: 28606761] |
| COLO 320 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human COLO 320 cells measured after 8 days
Cytotoxicity against human COLO 320 cells measured after 8 days
|
[PMID: 28606761] |
| COLO 320DM | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human COLO 320DM cells measured after 8 days
Cytotoxicity against human COLO 320DM cells measured after 8 days
|
[PMID: 28606761] |
| COLO-678 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human COLO-678 cells measured after 8 days
Cytotoxicity against human COLO-678 cells measured after 8 days
|
[PMID: 28606761] |
| COLO-741 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human COLO-741 cells measured after 8 days
Cytotoxicity against human COLO-741 cells measured after 8 days
|
[PMID: 28606761] |
| COR-L47 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human COR-L47 cells measured after 3 days
Cytotoxicity against human COR-L47 cells measured after 3 days
|
[PMID: 28606761] |
| CW-2 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CW-2 cells measured after 8 days
Cytotoxicity against human CW-2 cells measured after 8 days
|
[PMID: 28606761] |
| CWR22R | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human 22Rv1 cells after 8 days
Cytotoxicity against human 22Rv1 cells after 8 days
|
[PMID: 28606761] |
| CX-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human CX-1 cells measured after 8 days
Cytotoxicity against human CX-1 cells measured after 8 days
|
[PMID: 28606761] |
| DAN-G | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DAN-G cells measured after 8 days
Cytotoxicity against human DAN-G cells measured after 8 days
|
[PMID: 28606761] |
| Daudi | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Daudi cells measured after 8 days
Cytotoxicity against human Daudi cells measured after 8 days
|
[PMID: 28606761] |
| Daudi | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Daudi cells measured after 3 days
Cytotoxicity against human Daudi cells measured after 3 days
|
[PMID: 28606761] |
| DB | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DB cells measured after 8 days
Cytotoxicity against human DB cells measured after 8 days
|
[PMID: 28606761] |
| DB | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DB cells measured after 3 days
Cytotoxicity against human DB cells measured after 3 days
|
[PMID: 28606761] |
| DLD-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DLD-1 cells measured after 8 days
Cytotoxicity against human DLD-1 cells measured after 8 days
|
[PMID: 28606761] |
| DOHH-2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DOHH-2 cells measured after 3 days
Cytotoxicity against human DOHH-2 cells measured after 3 days
|
[PMID: 28606761] |
| DOV13 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DOV13 cells measured after 3 days
Cytotoxicity against human DOV13 cells measured after 3 days
|
[PMID: 28606761] |
| DU-145 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DU-145 cells measured after 8 days
Cytotoxicity against human DU-145 cells measured after 8 days
|
[PMID: 28606761] |
| DU-4475 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DU-4475 cells after 8 days
Cytotoxicity against human DU-4475 cells after 8 days
|
[PMID: 28606761] |
| DV-90 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human DV-90 cells measured after 8 days
Cytotoxicity against human DV-90 cells measured after 8 days
|
[PMID: 28606761] |
| EB2 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EB2 cells measured after 8 days
Cytotoxicity against human EB2 cells measured after 8 days
|
[PMID: 28606761] |
| EB2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EB2 cells measured after 3 days
Cytotoxicity against human EB2 cells measured after 3 days
|
[PMID: 28606761] |
| EB-3 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EB-3 cells measured after 8 days
Cytotoxicity against human EB-3 cells measured after 8 days
|
[PMID: 28606761] |
| EB-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EB-3 cells measured after 3 days
Cytotoxicity against human EB-3 cells measured after 3 days
|
[PMID: 28606761] |
| EBC-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EBC-1 cells after 8 days
Cytotoxicity against human EBC-1 cells after 8 days
|
[PMID: 28606761] |
| EFM-19 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EFM-19 cells measured after 3 days
Cytotoxicity against human EFM-19 cells measured after 3 days
|
[PMID: 28606761] |
| EFO-27 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EFO-27 cells measured after 3 days
Cytotoxicity against human EFO-27 cells measured after 3 days
|
[PMID: 28606761] |
| EJM | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EJM cells measured after 3 days
Cytotoxicity against human EJM cells measured after 3 days
|
[PMID: 28606761] |
| EKVX | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EKVX cells after 8 days
Cytotoxicity against human EKVX cells after 8 days
|
[PMID: 28606761] |
| EOL1 | IC50 |
1.34 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EOL1 cells measured after 8 days
Cytotoxicity against human EOL1 cells measured after 8 days
|
[PMID: 28606761] |
| EOL1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EOL1 cells measured after 3 days
Cytotoxicity against human EOL1 cells measured after 3 days
|
[PMID: 28606761] |
| EPLC-272H | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EPLC-272H cells measured after 8 days
Cytotoxicity against human EPLC-272H cells measured after 8 days
|
[PMID: 28606761] |
| ES-2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ES2 cells measured after 3 days
Cytotoxicity against human ES2 cells measured after 3 days
|
[PMID: 28606761] |
| EVSA-T | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human EVSA-T cells measured after 8 days
Cytotoxicity against human EVSA-T cells measured after 8 days
|
[PMID: 28606761] |
| G-402 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human G-402 cells measured after 3 days
Cytotoxicity against human G-402 cells measured after 3 days
|
[PMID: 28606761] |
| GA-10 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human GA-10 cells measured after 8 days
Cytotoxicity against human GA-10 cells measured after 8 days
|
[PMID: 28606761] |
| GP5d | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human GP5d cells measured after 8 days
Cytotoxicity against human GP5d cells measured after 8 days
|
[PMID: 28606761] |
| Granta-519 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Granta-519 cells measured after 8 days
Cytotoxicity against human Granta-519 cells measured after 8 days
|
[PMID: 28606761] |
| Granta-519 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Granta-519 cells measured after 3 days
Cytotoxicity against human Granta-519 cells measured after 3 days
|
[PMID: 28606761] |
| GTL 16 cell line | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human GTL 16 cell line measured after 8 days
Cytotoxicity against human GTL 16 cell line measured after 8 days
|
[PMID: 28606761] |
| HBL-100 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HBL-100 cells measured after 8 days
Cytotoxicity against human HBL-100 cells measured after 8 days
|
[PMID: 28606761] |
| HBL-100 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HBL-100 cells measured after 3 days
Cytotoxicity against human HBL-100 cells measured after 3 days
|
[PMID: 28606761] |
| HCC1143 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1143 cells measured after 8 days
Cytotoxicity against human HCC1143 cells measured after 8 days
|
[PMID: 28606761] |
| HCC1143 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1143 cells measured after 3 days
Cytotoxicity against human HCC1143 cells measured after 3 days
|
[PMID: 28606761] |
| HCC1187 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1187 cells measured after 3 days
Cytotoxicity against human HCC1187 cells measured after 3 days
|
[PMID: 28606761] |
| HCC1395 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1395 cells measured after 8 days
Cytotoxicity against human HCC1395 cells measured after 8 days
|
[PMID: 28606761] |
| HCC1395 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1395 cells measured after 3 days
Cytotoxicity against human HCC1395 cells measured after 3 days
|
[PMID: 28606761] |
| HCC1419 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1419 cells measured after 8 days
Cytotoxicity against human HCC1419 cells measured after 8 days
|
[PMID: 28606761] |
| HCC1419 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1419 cells measured after 3 days
Cytotoxicity against human HCC1419 cells measured after 3 days
|
[PMID: 28606761] |
| HCC1806 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1806 cells measured after 8 days
Cytotoxicity against human HCC1806 cells measured after 8 days
|
[PMID: 28606761] |
| HCC1937 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1937 cells measured after 8 days
Cytotoxicity against human HCC1937 cells measured after 8 days
|
[PMID: 28606761] |
| HCC1954 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1954 cells measured after 8 days
Cytotoxicity against human HCC1954 cells measured after 8 days
|
[PMID: 28606761] |
| HCC1954 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1954 cells measured after 3 days
Cytotoxicity against human HCC1954 cells measured after 3 days
|
[PMID: 28606761] |
| HCC2935 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC2935 cells after 8 days
Cytotoxicity against human HCC2935 cells after 8 days
|
[PMID: 28606761] |
| HCC38 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC38 cells measured after 8 days
Cytotoxicity against human HCC38 cells measured after 8 days
|
[PMID: 28606761] |
| HCC4006 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC4006 cells measured after 8 days
Cytotoxicity against human HCC4006 cells measured after 8 days
|
[PMID: 28606761] |
| HCC4017 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC4017 cells measured after 8 days
Cytotoxicity against human HCC4017 cells measured after 8 days
|
[PMID: 28606761] |
| HCC44 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC44 cells measured after 8 days
Cytotoxicity against human HCC44 cells measured after 8 days
|
[PMID: 28606761] |
| HCC515 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC515 cells measured after 8 days
Cytotoxicity against human HCC515 cells measured after 8 days
|
[PMID: 28606761] |
| HCC70 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC70 cells measured after 8 days
Cytotoxicity against human HCC70 cells measured after 8 days
|
[PMID: 28606761] |
| HCC70 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC70 cells measured after 3 days
Cytotoxicity against human HCC70 cells measured after 3 days
|
[PMID: 28606761] |
| HCC78 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC78 cells measured after 8 days
Cytotoxicity against human HCC78 cells measured after 8 days
|
[PMID: 28606761] |
| HCC827 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC827 cells measured after 8 days
Cytotoxicity against human HCC827 cells measured after 8 days
|
[PMID: 28606761] |
| HCC95 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC95 cells measured after 8 days
Cytotoxicity against human HCC95 cells measured after 8 days
|
[PMID: 28606761] |
| HCC95 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC95 cells measured after 3 days
Cytotoxicity against human HCC95 cells measured after 3 days
|
[PMID: 28606761] |
| HCT-116 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCT-116 cells measured after 8 days
Cytotoxicity against human HCT-116 cells measured after 8 days
|
[PMID: 28606761] |
| HCT-15 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCT-15 cells measured after 8 days
Cytotoxicity against human HCT-15 cells measured after 8 days
|
[PMID: 28606761] |
| HDQ-P1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HDQ-P1 cells measured after 8 days
Cytotoxicity against human HDQ-P1 cells measured after 8 days
|
[PMID: 28606761] |
| HEL | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HEL cells measured after 8 days
Cytotoxicity against human HEL cells measured after 8 days
|
[PMID: 28606761] |
| HEL | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HEL cells measured after 3 days
Cytotoxicity against human HEL cells measured after 3 days
|
[PMID: 28606761] |
| Hep 3B2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Hep 3B2.1-7 cells measured after 3 days
Cytotoxicity against human Hep 3B2.1-7 cells measured after 3 days
|
[PMID: 28606761] |
| HepG2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HepG2 cells measured after 3 days
Cytotoxicity against human HepG2 cells measured after 3 days
|
[PMID: 28606761] |
| HEY | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HEY cells measured after 8 days
Cytotoxicity against human HEY cells measured after 8 days
|
[PMID: 28606761] |
| HEY | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HEY cells measured after 3 days
Cytotoxicity against human HEY cells measured after 3 days
|
[PMID: 28606761] |
| HLE | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HLE cells measured after 3 days
Cytotoxicity against human HLE cells measured after 3 days
|
[PMID: 28606761] |
| HMEC | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against HMEC cells measured after 8 days
Cytotoxicity against HMEC cells measured after 8 days
|
[PMID: 28606761] |
| HOP-62 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HOP-62 cells measured after 8 days
Cytotoxicity against human HOP-62 cells measured after 8 days
|
[PMID: 28606761] |
| HOP-92 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HOP-92 cells measured after 8 days
Cytotoxicity against human HOP-92 cells measured after 8 days
|
[PMID: 28606761] |
| HPAC | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HPAC cells measured after 8 days
Cytotoxicity against human HPAC cells measured after 8 days
|
[PMID: 28606761] |
| Hs 294T | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Hs294T cells measured after 8 days
Cytotoxicity against human Hs294T cells measured after 8 days
|
[PMID: 28606761] |
| Hs-578T | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Hs-578T cells measured after 8 days
Cytotoxicity against human Hs-578T cells measured after 8 days
|
[PMID: 28606761] |
| HT | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HT cells measured after 8 days
Cytotoxicity against human HT cells measured after 8 days
|
[PMID: 28606761] |
| HT | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HT cells measured after 3 days
Cytotoxicity against human HT cells measured after 3 days
|
[PMID: 28606761] |
| HT-29 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HT-29 cells measured after 8 days
Cytotoxicity against human HT-29 cells measured after 8 days
|
[PMID: 28606761] |
| HuCCT-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HuCCT-1 cells measured after 3 days
Cytotoxicity against human HuCCT-1 cells measured after 3 days
|
[PMID: 28606761] |
| Huh-7 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Huh-7 cells measured after 3 days
Cytotoxicity against human Huh-7 cells measured after 3 days
|
[PMID: 28606761] |
| IGR-37 cell line | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human IGR-37 cell line measured after 8 days
Cytotoxicity against human IGR-37 cell line measured after 8 days
|
[PMID: 28606761] |
| IGROV-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human IGROV-1 cells measured after 8 days
Cytotoxicity against human IGROV-1 cells measured after 8 days
|
[PMID: 28606761] |
| IGROV-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human IGROV-1 cells measured after 3 days
Cytotoxicity against human IGROV-1 cells measured after 3 days
|
[PMID: 28606761] |
| IMR-32 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human IMR-32 cells measured after 3 days
Cytotoxicity against human IMR-32 cells measured after 3 days
|
[PMID: 28606761] |
| JeKo-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human JeKo-1 cells measured after 8 days
Cytotoxicity against human JeKo-1 cells measured after 8 days
|
[PMID: 28606761] |
| JeKo-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human JeKo-1 cells measured after 3 days
Cytotoxicity against human JeKo-1 cells measured after 3 days
|
[PMID: 28606761] |
| JIMT-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human JIMT-1 cells measured after 8 days
Cytotoxicity against human JIMT-1 cells measured after 8 days
|
[PMID: 28606761] |
| JIYOYE | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human JIYOYE cells measured after 3 days
Cytotoxicity against human JIYOYE cells measured after 3 days
|
[PMID: 28606761] |
| JJN-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human JJN-3 cells measured after 3 days
Cytotoxicity against human JJN-3 cells measured after 3 days
|
[PMID: 28606761] |
| Jurkat | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Jurkat cells measured after 3 days
Cytotoxicity against human Jurkat cells measured after 3 days
|
[PMID: 28606761] |
| K562 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human K562 cells measured after 8 days
Cytotoxicity against human K562 cells measured after 8 days
|
[PMID: 28606761] |
| K562 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human K562 cells measured after 3 days
Cytotoxicity against human K562 cells measured after 3 days
|
[PMID: 28606761] |
| KARPAS-422 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KARPAS-422 cells measured after 8 days
Cytotoxicity against human KARPAS-422 cells measured after 8 days
|
[PMID: 28606761] |
| KARPAS-422 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KARPAS-422 cells measured after 3 days
Cytotoxicity against human KARPAS-422 cells measured after 3 days
|
[PMID: 28606761] |
| KG-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KG-1 cells measured after 3 days
Cytotoxicity against human KG-1 cells measured after 3 days
|
[PMID: 28606761] |
| KMM-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KMM-1 cells measured after 8 days
Cytotoxicity against human KMM-1 cells measured after 8 days
|
[PMID: 28606761] |
| KMM-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KMM-1 cells measured after 3 days
Cytotoxicity against human KMM-1 cells measured after 3 days
|
[PMID: 28606761] |
| KMS-11 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KMS-11 cells measured after 3 days
Cytotoxicity against human KMS-11 cells measured after 3 days
|
[PMID: 28606761] |
| KMS-12-BM | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KMS-12-BM cells measured after 3 days
Cytotoxicity against human KMS-12-BM cells measured after 3 days
|
[PMID: 28606761] |
| KMS-12-PE | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KMS-12-PE cells measured after 3 days
Cytotoxicity against human KMS-12-PE cells measured after 3 days
|
[PMID: 28606761] |
| KNS-62 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KNS-62 cells measured after 8 days
Cytotoxicity against human KNS-62 cells measured after 8 days
|
[PMID: 28606761] |
| KP-4 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KP-4 cells measured after 8 days
Cytotoxicity against human KP-4 cells measured after 8 days
|
[PMID: 28606761] |
| KU812 cell line | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human KU812 cell line measured after 3 days
Cytotoxicity against human KU812 cell line measured after 3 days
|
[PMID: 28606761] |
| L-363 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human L-363 cells measured after 3 days
Cytotoxicity against human L-363 cells measured after 3 days
|
[PMID: 28606761] |
| LCLC-103H cell line | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LCLC-103H cell line measured after 8 days
Cytotoxicity against human LCLC-103H cell line measured after 8 days
|
[PMID: 28606761] |
| LCLC-97TM1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LCLC-97TM1 cells measured after 8 days
Cytotoxicity against human LCLC-97TM1 cells measured after 8 days
|
[PMID: 28606761] |
| LN-18 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LN-18 cells measured after 3 days
Cytotoxicity against human LN-18 cells measured after 3 days
|
[PMID: 28606761] |
| LN-229 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LN-229 cells measured after 3 days
Cytotoxicity against human LN-229 cells measured after 3 days
|
[PMID: 28606761] |
| LNCaP | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LNCaP clone FGC cells measured after 8 days
Cytotoxicity against human LNCaP clone FGC cells measured after 8 days
|
[PMID: 28606761] |
| LNCaP | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LNCaP/Ner cells measured after 8 days
Cytotoxicity against human LNCaP/Ner cells measured after 8 days
|
[PMID: 28606761] |
| LoVo | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LoVo cells measured after 8 days
Cytotoxicity against human LoVo cells measured after 8 days
|
[PMID: 28606761] |
| LP-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LP-1 cells measured after 8 days
Cytotoxicity against human LP-1 cells measured after 8 days
|
[PMID: 28606761] |
| LP-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LP-1 cells measured after 3 days
Cytotoxicity against human LP-1 cells measured after 3 days
|
[PMID: 28606761] |
| LS-1034 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LS1034 cells measured after 8 days
Cytotoxicity against human LS1034 cells measured after 8 days
|
[PMID: 28606761] |
| LS180 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LS180 cells measured after 8 days
Cytotoxicity against human LS180 cells measured after 8 days
|
[PMID: 28606761] |
| LXF-289 cell line | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human LXF-289 cell line measured after 8 days
Cytotoxicity against human LXF-289 cell line measured after 8 days
|
[PMID: 28606761] |
| MC116 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MC116 cells measured after 8 days
Cytotoxicity against human MC116 cells measured after 8 days
|
[PMID: 28606761] |
| MC116 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MC116 cells measured after 3 days
Cytotoxicity against human MC116 cells measured after 3 days
|
[PMID: 28606761] |
| MCF-10A | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MCF-10A cells measured after 3 days
Cytotoxicity against human MCF-10A cells measured after 3 days
|
[PMID: 28606761] |
| MCF7 | IC50 |
1.34 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MCF7 cells measured after 8 days
Cytotoxicity against human MCF7 cells measured after 8 days
|
[PMID: 28606761] |
| MCF7 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MCF-7-SER cells measured after 8 days
Cytotoxicity against human MCF-7-SER cells measured after 8 days
|
[PMID: 28606761] |
| MDA-MB-157 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-157 cells measured after 8 days
Cytotoxicity against human MDA-MB-157 cells measured after 8 days
|
[PMID: 28606761] |
| MDA-MB-175-VII | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-175-VII cells measured after 3 days
Cytotoxicity against human MDA-MB-175-VII cells measured after 3 days
|
[PMID: 28606761] |
| MDA-MB-231 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-231 cells measured after 8 days
Cytotoxicity against human MDA-MB-231 cells measured after 8 days
|
[PMID: 28606761] |
| MDA-MB-361 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-361 cells measured after 3 days
Cytotoxicity against human MDA-MB-361 cells measured after 3 days
|
[PMID: 28606761] |
| MDA-MB-415 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-415 cells measured after 8 days
Cytotoxicity against human MDA-MB-415 cells measured after 8 days
|
[PMID: 28606761] |
| MDA-MB-436 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-436 cells measured after 8 days
Cytotoxicity against human MDA-MB-436 cells measured after 8 days
|
[PMID: 28606761] |
| MDA-MB-453 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-453 cells measured after 3 days
Cytotoxicity against human MDA-MB-453 cells measured after 3 days
|
[PMID: 28606761] |
| MDA-MB-468 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MDA-MB-468 cells measured after 8 days
Cytotoxicity against human MDA-MB-468 cells measured after 8 days
|
[PMID: 28606761] |
| MEL-HO | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MEL-HO cells measured after 8 days
Cytotoxicity against human MEL-HO cells measured after 8 days
|
[PMID: 28606761] |
| MEL-HO | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MEL-HO cells measured after 3 days
Cytotoxicity against human MEL-HO cells measured after 3 days
|
[PMID: 28606761] |
| MEL-JUSO | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MEL-JUSO cells measured after 8 days
Cytotoxicity against human MEL-JUSO cells measured after 8 days
|
[PMID: 28606761] |
| MFM-223 | IC50 |
1.46 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MFM-223 cells measured after 8 days
Cytotoxicity against human MFM-223 cells measured after 8 days
|
[PMID: 28606761] |
| MFM-223 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MFM-223 cells measured after 3 days
Cytotoxicity against human MFM-223 cells measured after 3 days
|
[PMID: 28606761] |
| MHH-PREB-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MHH-PREB-1 cells measured after 8 days
Cytotoxicity against human MHH-PREB-1 cells measured after 8 days
|
[PMID: 28606761] |
| MHH-PREB-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MHH-PREB-1 cells measured after 3 days
Cytotoxicity against human MHH-PREB-1 cells measured after 3 days
|
[PMID: 28606761] |
| MKN-45 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MKN-45 cells measured after 8 days
Cytotoxicity against human MKN-45 cells measured after 8 days
|
[PMID: 28606761] |
| ML-2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ML-2 cells measured after 3 days
Cytotoxicity against human ML-2 cells measured after 3 days
|
[PMID: 28606761] |
| MOLM-13 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MOLM-13 cells measured after 3 days
Cytotoxicity against human MOLM-13 cells measured after 3 days
|
[PMID: 28606761] |
| MOLM-16 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MOLM16 cells measured after 8 days
Cytotoxicity against human MOLM16 cells measured after 8 days
|
[PMID: 28606761] |
| MOLM-16 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MOLM16 cells measured after 3 days
Cytotoxicity against human MOLM16 cells measured after 3 days
|
[PMID: 28606761] |
| MOLP-8 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MOLP8 cells measured after 3 days
Cytotoxicity against human MOLP8 cells measured after 3 days
|
[PMID: 28606761] |
| MV4-11 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MV4-11 cells measured after 8 days
Cytotoxicity against human MV4-11 cells measured after 8 days
|
[PMID: 28606761] |
| MX1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MX1 cells measured after 8 days
Cytotoxicity against human MX1 cells measured after 8 days
|
[PMID: 28606761] |
| MX1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human MX1 cells measured after 3 days
Cytotoxicity against human MX1 cells measured after 3 days
|
[PMID: 28606761] |
| NALM-6 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NALM-6 cells measured after 3 days
Cytotoxicity against human NALM-6 cells measured after 3 days
|
[PMID: 28606761] |
| NAMALVA | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NAMALVA cells measured after 8 days
Cytotoxicity against human NAMALVA cells measured after 8 days
|
[PMID: 28606761] |
| NAMALVA | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NAMALVA cells measured after 3 days
Cytotoxicity against human NAMALVA cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H1155 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1155 cells measured after 8 days
Cytotoxicity against human NCI-H1155 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1299 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1299 cells measured after 8 days
Cytotoxicity against human NCI-H1299 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1355 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1355 cells measured after 8 days
Cytotoxicity against human NCI-H1355 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1437 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1437 cells measured after 8 days
Cytotoxicity against human NCI-H1437 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H146 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H146 cells measured after 8 days
Cytotoxicity against human NCI-H146 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1573 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1573 cells after 8 days
Cytotoxicity against human NCI-H1573 cells after 8 days
|
[PMID: 28606761] |
| NCI-H1581 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1581 cells measured after 8 days
Cytotoxicity against human NCI-H1581 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1651 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1651 cells measured after 8 days
Cytotoxicity against human NCI-H1651 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1666 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1666 cells measured after 8 days
Cytotoxicity against human NCI-H1666 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1703 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1703 cells measured after 8 days
Cytotoxicity against human NCI-H1703 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1734 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1734 cells measured after 3 days
Cytotoxicity against human NCI-H1734 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H1770 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human HCC1770 cells measured after 8 days
Cytotoxicity against human HCC1770 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1793 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1793 cells measured after 8 days
Cytotoxicity against human NCI-H1793 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1838 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1838 cells measured after 8 days
Cytotoxicity against human NCI-H1838 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1944 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1944 cells measured after 8 days
Cytotoxicity against human NCI-H1944 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1944 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1944 cells measured after 3 days
Cytotoxicity against human NCI-H1944 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H1975 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1975 cells measured after 8 days
Cytotoxicity against human NCI-H1975 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H1993 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H1993 cells measured after 8 days
Cytotoxicity against human NCI-H1993 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2009 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2009 cells measured after 8 days
Cytotoxicity against human NCI-H2009 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2030 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2030 cells measured after 8 days
Cytotoxicity against human NCI-H2030 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2122 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2122 cells measured after 8 days
Cytotoxicity against human NCI-H2122 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2170 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2170 cells measured after 3 days
Cytotoxicity against human NCI-H2170 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H2228 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2228 cells measured after 8 days
Cytotoxicity against human NCI-H2228 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H226 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H226 cells measured after 8 days
Cytotoxicity against human NCI-H226 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H23 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H23 cells measured after 8 days
Cytotoxicity against human NCI-H23 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2347 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2347 cells measured after 8 days
Cytotoxicity against human NCI-H2347 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2405 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2405 cells measured after 8 days
Cytotoxicity against human NCI-H2405 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H2444 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2444 cells measured after 3 days
Cytotoxicity against human NCI-H2444 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H2452 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H2452 cells measured after 8 days
Cytotoxicity against human NCI-H2452 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H28 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H28 cells measured after 8 days
Cytotoxicity against human NCI-H28 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H292 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H292 cells measured after 8 days
Cytotoxicity against human NCI-H292 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H358 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H358 cells measured after 8 days
Cytotoxicity against human NCI-H358 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H441 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H441 cells measured after 8 days
Cytotoxicity against human NCI-H441 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H460 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H460 cells measured after 8 days
Cytotoxicity against human NCI-H460 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H460 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H460 cells measured after 3 days
Cytotoxicity against human NCI-H460 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H520 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H520 cells measured after 8 days
Cytotoxicity against human NCI-H520 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H520 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H520 cells measured after 3 days
Cytotoxicity against human NCI-H520 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H522 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H522 cells measured after 8 days
Cytotoxicity against human NCI-H522 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H647 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H647 cells measured after 8 days
Cytotoxicity against human NCI-H647 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H647 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H647 cells measured after 3 days
Cytotoxicity against human NCI-H647 cells measured after 3 days
|
[PMID: 28606761] |
| NCI-H650 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H650 cells measured after 8 days
Cytotoxicity against human NCI-H650 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H661 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H661 cells measured after 8 days
Cytotoxicity against human NCI-H661 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H727 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H727 cells measured after 8 days
Cytotoxicity against human NCI-H727 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H82 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H82 cells measured after 8 days
Cytotoxicity against human NCI-H82 cells measured after 8 days
|
[PMID: 28606761] |
| NCI-H929 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NCI-H929 cells measured after 3 days
Cytotoxicity against human NCI-H929 cells measured after 3 days
|
[PMID: 28606761] |
| NOMO-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NOMO-1 cells measured after 3 days
Cytotoxicity against human NOMO-1 cells measured after 3 days
|
[PMID: 28606761] |
| NUGC-4 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human NUGC-4 cells measured after 8 days
Cytotoxicity against human NUGC-4 cells measured after 8 days
|
[PMID: 28606761] |
| OAW-28 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OAW28 cells measured after 3 days
Cytotoxicity against human OAW28 cells measured after 3 days
|
[PMID: 28606761] |
| OAW-42 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OAW-42 cells measured after 3 days
Cytotoxicity against human OAW-42 cells measured after 3 days
|
[PMID: 28606761] |
| OCI-AML2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OCI-AML2 cells measured after 3 days
Cytotoxicity against human OCI-AML2 cells measured after 3 days
|
[PMID: 28606761] |
| OCI-AML-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OCI-AML-3 cells measured after 3 days
Cytotoxicity against human OCI-AML-3 cells measured after 3 days
|
[PMID: 28606761] |
| OCI-AML-5 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OCI-AML5 cells measured after 8 days
Cytotoxicity against human OCI-AML5 cells measured after 8 days
|
[PMID: 28606761] |
| OCI-AML-5 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OCI-AML5 cells measured after 3 days
Cytotoxicity against human OCI-AML5 cells measured after 3 days
|
[PMID: 28606761] |
| OCI-LY19 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OCILY19 cells measured after 8 days
Cytotoxicity against human OCILY19 cells measured after 8 days
|
[PMID: 28606761] |
| OCI-LY19 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OCILY19 cells measured after 3 days
Cytotoxicity against human OCILY19 cells measured after 3 days
|
[PMID: 28606761] |
| ONS-76 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ONS-76 cells measured after 8 days
Cytotoxicity against human ONS-76 cells measured after 8 days
|
[PMID: 28606761] |
| OPM-2 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OPM-2 cells measured after 8 days
Cytotoxicity against human OPM-2 cells measured after 8 days
|
[PMID: 28606761] |
| OPM-2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OPM-2 cells measured after 3 days
Cytotoxicity against human OPM-2 cells measured after 3 days
|
[PMID: 28606761] |
| OV-90 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OV-90 cells measured after 3 days
Cytotoxicity against human OV-90 cells measured after 3 days
|
[PMID: 28606761] |
| OVCAR-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OVCAR-3 cells measured after 3 days
Cytotoxicity against human OVCAR-3 cells measured after 3 days
|
[PMID: 28606761] |
| OVCAR-4 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OVCAR-4 cells measured after 3 days
Cytotoxicity against human OVCAR-4 cells measured after 3 days
|
[PMID: 28606761] |
| OVCAR-5 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OVCAR-5 cells measured after 3 days
Cytotoxicity against human OVCAR-5 cells measured after 3 days
|
[PMID: 28606761] |
| OVCAR-8 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human OVCAR-8 cells measured after 3 days
Cytotoxicity against human OVCAR-8 cells measured after 3 days
|
[PMID: 28606761] |
| PA-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human PA-1 cells measured after 8 days
Cytotoxicity against human PA-1 cells measured after 8 days
|
[PMID: 28606761] |
| PA-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human PA-1 cells measured after 3 days
Cytotoxicity against human PA-1 cells measured after 3 days
|
[PMID: 28606761] |
| PC-3 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human PC-3 cells measured after 8 days
Cytotoxicity against human PC-3 cells measured after 8 days
|
[PMID: 28606761] |
| PC-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human PC-3 cells measured after 3 days
Cytotoxicity against human PC-3 cells measured after 3 days
|
[PMID: 28606761] |
| PEO1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human PEO1 cells measured after 3 days
Cytotoxicity against human PEO1 cells measured after 3 days
|
[PMID: 28606761] |
| PLC-PRF-5 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human PLC-PRF-5 cells measured after 3 days
Cytotoxicity against human PLC-PRF-5 cells measured after 3 days
|
[PMID: 28606761] |
| Raji | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Raji cells measured after 8 days
Cytotoxicity against human Raji cells measured after 8 days
|
[PMID: 28606761] |
| Raji | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Raji cells measured after 3 days
Cytotoxicity against human Raji cells measured after 3 days
|
[PMID: 28606761] |
| Ramos | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Ramos cells measured after 8 days
Cytotoxicity against human Ramos cells measured after 8 days
|
[PMID: 28606761] |
| Ramos | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human Ramos cells measured after 3 days
Cytotoxicity against human Ramos cells measured after 3 days
|
[PMID: 28606761] |
| Rec1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human REC1 cells measured after 3 days
Cytotoxicity against human REC1 cells measured after 3 days
|
[PMID: 28606761] |
| RERF-LC-MS | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RERF-LC-MS cells measured after 8 days
Cytotoxicity against human RERF-LC-MS cells measured after 8 days
|
[PMID: 28606761] |
| RKO | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RKO cells measured after 8 days
Cytotoxicity against human RKO cells measured after 8 days
|
[PMID: 28606761] |
| RL | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RL cells measured after 8 days
Cytotoxicity against human RL cells measured after 8 days
|
[PMID: 28606761] |
| RL | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RL cells measured after 3 days
Cytotoxicity against human RL cells measured after 3 days
|
[PMID: 28606761] |
| RMG-I | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RMG-I cells measured after 3 days
Cytotoxicity against human RMG-I cells measured after 3 days
|
[PMID: 28606761] |
| RPMI-8226 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RPMI-8226 cells measured after 3 days
Cytotoxicity against human RPMI-8226 cells measured after 3 days
|
[PMID: 28606761] |
| RS4-11 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human RS4-11 cells measured after 8 days
Cytotoxicity against human RS4-11 cells measured after 8 days
|
[PMID: 28606761] |
| SCC-3 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SCC-3 cells measured after 8 days
Cytotoxicity against human SCC-3 cells measured after 8 days
|
[PMID: 28606761] |
| SCC-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SCC-3 cells measured after 3 days
Cytotoxicity against human SCC-3 cells measured after 3 days
|
[PMID: 28606761] |
| SET-2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SET2 cells measured after 3 days
Cytotoxicity against human SET2 cells measured after 3 days
|
[PMID: 28606761] |
| SK-BR-3 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SK-BR-3 cells measured after 8 days
Cytotoxicity against human SK-BR-3 cells measured after 8 days
|
[PMID: 28606761] |
| SK-BR-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SK-BR-3 cells measured after 3 days
Cytotoxicity against human SK-BR-3 cells measured after 3 days
|
[PMID: 28606761] |
| SKM-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SKM-1 cells measured after 8 days
Cytotoxicity against human SKM-1 cells measured after 8 days
|
[PMID: 28606761] |
| SKM-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SKM-1 cells measured after 3 days
Cytotoxicity against human SKM-1 cells measured after 3 days
|
[PMID: 28606761] |
| SK-MEL-28 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SK-MEL-28 cells measured after 8 days
Cytotoxicity against human SK-MEL-28 cells measured after 8 days
|
[PMID: 28606761] |
| SK-MES-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SK-MES-1 cells measured after 8 days
Cytotoxicity against human SK-MES-1 cells measured after 8 days
|
[PMID: 28606761] |
| SK-MES-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SK-MES-1 cells measured after 3 days
Cytotoxicity against human SK-MES-1 cells measured after 3 days
|
[PMID: 28606761] |
| SK-OV-3 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SK-OV-3 cells measured after 3 days
Cytotoxicity against human SK-OV-3 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-182 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-182 cells measured after 3 days
Cytotoxicity against human SNU-182 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-387 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-387 cells measured after 3 days
Cytotoxicity against human SNU-387 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-398 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-398 cells measured after 3 days
Cytotoxicity against human SNU-398 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-423 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-423 cells measured after 3 days
Cytotoxicity against human SNU-423 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-449 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-449 cells measured after 3 days
Cytotoxicity against human SNU-449 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-475 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-475 cells measured after 3 days
Cytotoxicity against human SNU-475 cells measured after 3 days
|
[PMID: 28606761] |
| SNU-C1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SNU-C1 cells measured after 8 days
Cytotoxicity against human SNU-C1 cells measured after 8 days
|
[PMID: 28606761] |
| SR | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SR cells measured after 8 days
Cytotoxicity against human SR cells measured after 8 days
|
[PMID: 28606761] |
| SR | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SR cells measured after 3 days
Cytotoxicity against human SR cells measured after 3 days
|
[PMID: 28606761] |
| SUD4 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-4 cells measured after 8 days
Cytotoxicity against human SU-DHL-4 cells measured after 8 days
|
[PMID: 28606761] |
| SUD4 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-4 cells measured after 3 days
Cytotoxicity against human SU-DHL-4 cells measured after 3 days
|
[PMID: 28606761] |
| SU-DHL-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-1 cells measured after 8 days
Cytotoxicity against human SU-DHL-1 cells measured after 8 days
|
[PMID: 28606761] |
| SU-DHL-1 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-1 cells measured after 3 days
Cytotoxicity against human SU-DHL-1 cells measured after 3 days
|
[PMID: 28606761] |
| SU-DHL10 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-10 cells measured after 3 days
Cytotoxicity against human SU-DHL-10 cells measured after 3 days
|
[PMID: 28606761] |
| SU-DHL-16 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-16 cells measured after 8 days
Cytotoxicity against human SU-DHL-16 cells measured after 8 days
|
[PMID: 28606761] |
| SU-DHL-16 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-16 cells measured after 3 days
Cytotoxicity against human SU-DHL-16 cells measured after 3 days
|
[PMID: 28606761] |
| SU-DHL-5 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-5 cells measured after 3 days
Cytotoxicity against human SU-DHL-5 cells measured after 3 days
|
[PMID: 28606761] |
| SU-DHL-6 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-6 cells measured after 3 days
Cytotoxicity against human SU-DHL-6 cells measured after 3 days
|
[PMID: 28606761] |
| SU-DHL-8 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SU-DHL-8 cells measured after 3 days
Cytotoxicity against human SU-DHL-8 cells measured after 3 days
|
[PMID: 28606761] |
| SUM149PT | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SUM149PT cells measured after 3 days
Cytotoxicity against human SUM149PT cells measured after 3 days
|
[PMID: 28606761] |
| SUM-159-PT | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SUM159PT cells measured after 3 days
Cytotoxicity against human SUM159PT cells measured after 3 days
|
[PMID: 28606761] |
| SUP-B15 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SUP-B15 cells measured after 3 days
Cytotoxicity against human SUP-B15 cells measured after 3 days
|
[PMID: 28606761] |
| SW1573 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW1573 cells measured after 8 days
Cytotoxicity against human SW1573 cells measured after 8 days
|
[PMID: 28606761] |
| SW1573 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW1573 cells measured after 3 days
Cytotoxicity against human SW1573 cells measured after 3 days
|
[PMID: 28606761] |
| SW48 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW48 cells measured after 8 days
Cytotoxicity against human SW48 cells measured after 8 days
|
[PMID: 28606761] |
| SW480 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW480 cells measured after 8 days
Cytotoxicity against human SW480 cells measured after 8 days
|
[PMID: 28606761] |
| SW-620 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW620 cells measured after 8 days
Cytotoxicity against human SW620 cells measured after 8 days
|
[PMID: 28606761] |
| SW626 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW626 cells measured after 3 days
Cytotoxicity against human SW626 cells measured after 3 days
|
[PMID: 28606761] |
| SW948 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW948 cells measured after 8 days
Cytotoxicity against human SW948 cells measured after 8 days
|
[PMID: 28606761] |
| SW982 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human SW982 cells measured after 3 days
Cytotoxicity against human SW982 cells measured after 3 days
|
[PMID: 28606761] |
| T47D | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human T47D cells measured after 8 days
Cytotoxicity against human T47D cells measured after 8 days
|
[PMID: 28606761] |
| T47D | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human T47D cells measured after 3 days
Cytotoxicity against human T47D cells measured after 3 days
|
[PMID: 28606761] |
| T98G | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human T98G cells measured after 3 days
Cytotoxicity against human T98G cells measured after 3 days
|
[PMID: 28606761] |
| TERT-RPE1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against hTERT-RPE1 cells measured after 8 days
Cytotoxicity against hTERT-RPE1 cells measured after 8 days
|
[PMID: 28606761] |
| TK-10 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human TK-10 cells measured after 3 days
Cytotoxicity against human TK-10 cells measured after 3 days
|
[PMID: 28606761] |
| TMD8 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human TMD8 cells measured after 3 days
Cytotoxicity against human TMD8 cells measured after 3 days
|
[PMID: 28606761] |
| TOV112D | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human TOV112D cells measured after 3 days
Cytotoxicity against human TOV112D cells measured after 3 days
|
[PMID: 28606761] |
| TOV21G | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human TOV-21G cells measured after 3 days
Cytotoxicity against human TOV-21G cells measured after 3 days
|
[PMID: 28606761] |
| TYK-nu | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human TYK-nu cells measured after 3 days
Cytotoxicity against human TYK-nu cells measured after 3 days
|
[PMID: 28606761] |
| U-266 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human U266B1 cells measured after 3 days
Cytotoxicity against human U266B1 cells measured after 3 days
|
[PMID: 28606761] |
| U-698-M | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human U-698-M cells measured after 8 days
Cytotoxicity against human U-698-M cells measured after 8 days
|
[PMID: 28606761] |
| U-698-M | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human U-698-M cells measured after 3 days
Cytotoxicity against human U-698-M cells measured after 3 days
|
[PMID: 28606761] |
| U-937 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human U-937 cells measured after 8 days
Cytotoxicity against human U-937 cells measured after 8 days
|
[PMID: 28606761] |
| U-937 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human U-937 cells measured after 3 days
Cytotoxicity against human U-937 cells measured after 3 days
|
[PMID: 28606761] |
| UACC-62 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human UACC-62 cells measured after 8 days
Cytotoxicity against human UACC-62 cells measured after 8 days
|
[PMID: 28606761] |
| UMC-11 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human UMC-11 cells measured after 8 days
Cytotoxicity against human UMC-11 cells measured after 8 days
|
[PMID: 28606761] |
| WiDr | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human WiDr cells measured after 8 days
Cytotoxicity against human WiDr cells measured after 8 days
|
[PMID: 28606761] |
| WSUDLCL2 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human WSUDLCL2 cells measured after 8 days
Cytotoxicity against human WSUDLCL2 cells measured after 8 days
|
[PMID: 28606761] |
| WSUDLCL2 | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human WSUDLCL2 cells measured after 3 days
Cytotoxicity against human WSUDLCL2 cells measured after 3 days
|
[PMID: 28606761] |
| YMB-1-E | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human YMB-1-E cells measured after 8 days
Cytotoxicity against human YMB-1-E cells measured after 8 days
|
[PMID: 28606761] |
| YMB-1-E | IC50 |
5 μM
Compound: 11; GNE-375
|
Cytotoxicity against human YMB-1-E cells measured after 3 days
Cytotoxicity against human YMB-1-E cells measured after 3 days
|
[PMID: 28606761] |
| ZR-75-1 | IC50 |
2 μM
Compound: 11; GNE-375
|
Cytotoxicity against human ZR-75-1 cells measured after 8 days
Cytotoxicity against human ZR-75-1 cells measured after 8 days
|
[PMID: 28606761] |
Chemical Information
-
CAS No. 1926989-06-1
-
Appearance Solid
-
Molecular Weight 451.51
-
Formula C25H29N3O5
-
Color Off-white to pink
-
SMILES
O=C1C(NC(C)=C2)=C2C(C3=CC(OC)=C(C(N4CCOCC4)=O)C=C3OC)=CN1C/C=C/C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 50 mg/mL (110.74 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2148 mL | 11.0740 mL | 22.1479 mL | 55.3698 mL |
| 5 mM | 0.4430 mL | 2.2148 mL | 4.4296 mL | 11.0740 mL | |
| 10 mM | 0.2215 mL | 1.1074 mL | 2.2148 mL | 5.5370 mL | |
| 15 mM | 0.1477 mL | 0.7383 mL | 1.4765 mL | 3.6913 mL | |
| 20 mM | 0.1107 mL | 0.5537 mL | 1.1074 mL | 2.7685 mL | |
| 25 mM | 0.0886 mL | 0.4430 mL | 0.8859 mL | 2.2148 mL | |
| 30 mM | 0.0738 mL | 0.3691 mL | 0.7383 mL | 1.8457 mL | |
| 40 mM | 0.0554 mL | 0.2768 mL | 0.5537 mL | 1.3842 mL | |
| 50 mM | 0.0443 mL | 0.2215 mL | 0.4430 mL | 1.1074 mL | |
| 60 mM | 0.0369 mL | 0.1846 mL | 0.3691 mL | 0.9228 mL | |
| 80 mM | 0.0277 mL | 0.1384 mL | 0.2768 mL | 0.6921 mL | |
| 100 mM | 0.0221 mL | 0.1107 mL | 0.2215 mL | 0.5537 mL |